Week in Review: Celebrating Patient Health

Week in Review: Celebrating Patient Health

07.03.14 | By

Before we leave to celebrate the holiday weekend, we wanted to talk about the latest happenings in the biopharmaceutical industry and the importance of celebrating patients.

Researcher and patient advocate Sue Dubman discussed her battle with Parkinson’s disease and participating in clinical trials. There are currently 37 medicines in the pipeline to help treat patients with Parkinson’s disease, but without clinical trial participants, Sue says, new treatments will not be developed to help suffering patients. Thanks to the willingness of brave patients like Sue who enroll in clinical trials, we are making progress and helping patients live longer, healthier lives. If you’re interested in participating, you can use the Fox Trial Finder, which is what Sue did, and she urges others to not waste time and act now.

Patients are our priority, and this week, we continued our Burden on Patients blog series which discusses the potential barriers to access that mental health and Multiple Sclerosis (MS) patients could face in the Affordable Care Act (ACA) health insurance exchange plans. Each week, the Burden on Patients blog series will give you a by-the-numbers breakdown of how health insurance exchange plans make accessing needed medicines more difficult for patients, which ultimately hinders medication adherence for those suffering from chronic illness. Check back next week for a new posts on asthma and diabetes.

While working to ensure access to treatments for mental health patients under the ACA, the biopharmaceutical industry is also working to broaden treatment options for patients. Last week Representatives Leonard Lance and Doris Matsui hosted PhRMA and others at a Mental Health Capitol Hill briefing to discuss the importance of research and development (R&D) for mental health patients. With 119 medicines in the pipeline to treat mental health disorders such as schizophrenia, depression and anxiety disorders, panelists agreed that innovative new medicines are vital to patient health. Through continued discussion and collaboration we can ensure innovative breakthroughs and a brighter future for patients.

We want to wish all of our readers a safe and happy Fourth of July. While we hope for clear skies and great grilling conditions, Tropical Storm Arthur is headed our way and may foil those plans. For those in its path, please take necessary precautions and utilize online tools such as RX Response to be prepared for any medical needs that may arise. We will catch back up with you next week. Happy Fourth of July!


Hide Comments

More On PhRMA — powered by PhRMApedia


Cost in Context